Abstract
Central nervous system inflammatory demyelinating disease can affect patients across the life span. Consensus definitions and criteria of all of the different acquired demyelinating diseases that fall on this spectrum have magnetic resonance imaging criteria. The advances of both neuroimaging techniques and important discoveries in immunology have produced an improved understanding of these conditions and classification. Neuroimaging plays a central role in the accurate diagnosis, prognosis, disease monitoring and research efforts that are being undertaken in this disease. This review focuses on the imaging spectrum of acquired demyelinating disease.
Original language | English (US) |
---|---|
Pages (from-to) | 249-268 |
Number of pages | 20 |
Journal | Therapeutic Advances in Neurological Disorders |
Volume | 6 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2013 |
Keywords
- MRI
- demyelinating disease
- multiple sclerosis
- neuroimaging
ASJC Scopus subject areas
- Pharmacology
- Neurology
- Clinical Neurology